United States Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

The “United States Cardiac Rhythm Management Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

The United States Cardiac Rhythm Management Devices Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Cardiac Rhythm Management Devices Market.
Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

United States Cardiac Rhythm Management Devices is segmented as follows:

Cardiac Resynchronisation Therapy (CRT)
Implantable Cardioverter Defibrillators (ICD)
Pacemakers

Reasons to Buy

The United States Cardiac Rhythm Management Devices Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, United States

3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market

4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Biotronik SE & Co KG
4.4.1 Company Overview
4.5 MicroPort Scientific Corp
4.5.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Financial Deals Landscape

6.1 Equity Offerings
6.1.1 EBR Systems to Raise USD25.26 Million in Private Placement of Shares
6.1.2 EBR Systems Raises USD5.74 Million in Entitlement Offer of Shares
6.2 Partnerships
6.2.1 iRhythm Technologies Enters into Licensing Agreement with BioIntellisense

7 Recent Developments

7.1 Corporate Communications
7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.2 Financial Announcements
7.2.1 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results
7.2.2 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
7.2.3 Apr 07, 2025: CVRx Announces Preliminary Q1 2025 Results
7.2.4 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
7.2.5 Jan 21, 2025: CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
7.2.6 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
7.2.7 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.8 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
7.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.3 Government and Public Interest
7.3.1 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences
7.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
7.3.3 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
7.3.4 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
7.3.5 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
7.4 Product News
7.4.1 Feb 03, 2025: Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
7.4.2 Sep 26, 2024: Engineering Human Heart Tissue for Scientific Study
7.5 Strategy And Business Planning
7.5.1 Jan 28, 2025: EBR Leases New Facility to Expand Manufacturing Capabilities

8 Appendix

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

List of Tables

Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
Table 8: Pacemakers Market, United States, Volume (Units), 2018-2033
Table 9: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
Table 10: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024
Table 11: Cardiac Rhythm Management Devices Market Pipeline Products
Table 12: EBR Systems to Raise USD25.26 Million in Private Placement of Shares
Table 13: EBR Systems Raises USD5.74 Million in Entitlement Offer of Shares
Table 14: iRhythm Technologies Enters into Licensing Agreement with BioIntellisense
Table 15: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

List of Figures

Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
Figure 8: Pacemakers Market, United States, Volume (Units), 2018-2033
Figure 9: Cardiac Rhythm Management Devices Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Biotronik SE & Co KG
Boston Scientific Corp
EBR Systems Inc
Medtronic Plc
MicroPort Scientific Corp

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4402EUR$4,995USD£3,866GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€8803EUR$9,990USD£7,732GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13205EUR$14,985USD£11,598GBP

The United States Cardiac Rhythm Management Devices Market report provides key information and data on:

Report Scope

United States Cardiac Rhythm Management Devices is segmented as follows:

Reasons to Buy

The United States Cardiac Rhythm Management Devices Market report helps you to develop:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Implantable Cardioverter Defibrillators (ICD) Market Size By Segments, Share, Regulatory, Reimbursement, Interventions And Forecast To 2036

Canada Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

U.S. Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), And Segment Forecasts, 2025 - 2033

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), By End Use, By Region, And Segment Forecasts, 2025 - 2033

Defibrillators Market Report by Product Type, End-User, and Region 2025-2033